BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 10459558)

  • 1. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
    De Mitrio V; De Pergola G; Vettor R; Marino R; Sciaraffia M; Pagano C; Scaraggi FA; Di Lorenzo L; Giorgino R
    Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.
    De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R
    Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.
    Polac I; Stachowiak G; Jedrzejczyk S; Stetkiewics T; Sobieszczanska S; Pertynski T
    Gynecol Endocrinol; 2003 Apr; 17(2):151-7. PubMed ID: 12744226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
    Sudi KM; Gallistl S; Weinhandl G; Muntean W; Borkenstein MH
    Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women.
    Janand-Delenne B; Chagnaud C; Raccah D; Alessi MC; Juhan-Vague I; Vague P
    Int J Obes Relat Metab Disord; 1998 Apr; 22(4):312-7. PubMed ID: 9578235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents.
    Huang KC; Lin RC; Kormas N; Lee LT; Chen CY; Gill TP; Caterson ID
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):470-5. PubMed ID: 14993909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans.
    Fernández-Real JM; Sanchis D; Ricart W; Casamitjana R; Balada F; Remesar X; Alemany M
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):253-60. PubMed ID: 10396370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study in the relationships between leptin, insulin, and body fat in Asian subjects.
    Ho SC; Tai ES; Eng PH; Ramli A; Tan CE; Fok AC
    Int J Obes Relat Metab Disord; 1999 Mar; 23(3):246-52. PubMed ID: 10193869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.
    Mykkänen L; Rönnemaa T; Marniemi J; Haffner SM; Bergman R; Laakso M
    Arterioscler Thromb; 1994 Aug; 14(8):1264-71. PubMed ID: 8049187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery.
    Ciccone M; Vettor R; Pannacciulli N; Minenna A; Bellacicco M; Rizzon P; Giorgino R; De Pergola G
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):805-10. PubMed ID: 11439293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.
    Cigolini M; Targher G; Seidell JC; Schiavon R; Manara F; Zenti MG; Mattioli C; De Sandre G
    Atherosclerosis; 1994 Apr; 106(2):139-47. PubMed ID: 8060375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Volpato S; Palmieri E; Mezzetti A; Vergnani L; Fellin R
    Metabolism; 1998 May; 47(5):535-40. PubMed ID: 9591743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.
    Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani G
    Thromb Res; 1994 Aug; 75(3):223-31. PubMed ID: 7992233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
    van Harmelen V; Wahrenberg H; Eriksson P; Arner P
    Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum GHBP levels in obese pubertal children and adolescents: relationship to body composition, leptin and indicators of metabolic disturbances.
    Kratzsch J; Dehmel B; Pulzer F; Keller E; Englaro P; Blum WF; Wabitsch M
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1130-6. PubMed ID: 9426380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
    Nagi DK; Tracy R; Pratley R
    Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.